Our Mission & VisionHistory of THETATHETA News ArchiveTHETA Staff & CommunityContact Us
Health Modelling and Health EconomicsClinical ResearchHealth Policy and Ethics
Current StudiesCompleted Studies
THETA Quarterly NewsletterReportsWorking PapersPublicationsPresentationsTHETA KT Day & Symposium
Health Technology Assessment InstituteTHETA RoundsHTA Courses
HTA OrganizationsHTA ConferencesHTA Resources & Tools
This is the "Home" page of the "Welcome to Toronto Health Economics and Technology Assessment Collaborative" guide.
Alternate Page for Screenreader Users
Skip to Page Navigation
Skip to Page Content

Welcome to Toronto Health Economics and Technology Assessment Collaborative  

Last Updated: Aug 18, 2014 URL: http://theta.utoronto.ca/home Print Guide RSS Updates

Home Print Page
  Search: 
 
 

.

  • THETA team

  • ...will be back in September 2014.
    Please check under Education > THETA Rounds tab for upcoming Fall schedule.
Image Slideshow Website by WOWSlider.com v3.4
 

RECENTLY PUBLISHED



After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. - Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, Hak E.
Publication Date: 2014 Jul
Journal of Clinical Epidemiology 2014 ;67(7):734-44. doi: 10.1016/j.jclinepi.2014.02.009. Epub 2014 Apr 24. PMID: 24768004 [PubMed - in process]



Screening for HCV. - Wong WW, Krahn M
Publication Date: March 4, 2014
CMAJ. ;186(4):294.










Disease burden of chronic hepatitis B among Immigrants in Canada. - Wong W W L, Woo G, Heathcote JE, Krahn M.
Publication Date: March, 2013
Canadian Journal of Gastroenterology. 27(3):137-147

 

UPCOMING EVENTS

THETA Rounds

Since 2008 THETA has been hosting  a lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assesment field. Recordings of some sessions are available in the THETA Rounds Archive.
 

Please note: THETA Rounds will be offered again in September 2014. Please check in August under Education > THETA Rounds tab for the upcoming Fall schedule.

 


PAST EVENTS

Health Technology Assessment for Decision Makers course

Every year since 2011 the HTA Institute offered the Health Technology Assessment for Decision Makers course. Register now for July 14-16, 2014 session at Dalhousie University.

The Canadian Agency for Drugs and Technologies in Health (CADTH), in association with the Toronto Health Economics and Technology Assessment Collaborative (THETA) and Maritime Strategy for Patient-Oriented Research Support Unit (MSSU), is pleased to offer the 2014 Health Technology Assessment for Decision Makers course at a reduced rate! Please click here for details.

The HTA Institute will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course will be useful to individuals who use HTA to make decisions relating to drugs, devices, and programs.

Space is limited. Please register by July 9th!



 Topic: Role of Health Economics and its Specificities in the Dutch Reimbursement of Vaccines

Lecturer: Prof Maarten J Postma (University of Groningen)
Date: Friday, May 30, 2014
Time:
1:00pm - 2:00pm
Venue:
Health Sciences Bld, 155 College St., Rm 106

 
 

Topic: Making Public Decisions about Health: Cost-Effectiveness and Cost-Benefit Analysis
Lecturer: Louise B. Russell, (Ph.D., Economics, Harvard) is Distinguished Professor at the Institute and in the Department of Economics, Rutgers University
Date: Friday, May 9, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850

 


Topic: Supervised Injection Facilities in Toronto and Ottawa: Evidence, Models, and Policies
Lecturer: Dr. Ahmed Bayoumi, MD, MSc, FRCPC
Date: Friday, April 25, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850

 


PLEASE NOTE: this session has been rescheduled to April 11th and moved toRm # 255

Topic: Health care decision making in Mexico: The role of HTA and economic evaluation
Lecturer: Fernando Alarid, MS Economics, BSc Biomedical Engineering
Date: Friday, April 11, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 255

 


Topic: Evaluation of the Complex Interventions - THETA's experience  (Recording available)
Lecturer: Valeria E. Rac, MD, PhD
Date:
Friday,  March 7, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850



THETA Rounds

Since 2008 THETA has been hosting  a lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assesment field.
 

Topic: Is society getting a good return on its funding investment in medical research? Examining the quality of reports of medical research and strategies to maximize the outputs of the investments
Lecturer: Dr. David Moher
Date:
Friday,  March 7, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850



 

THETA Rounds

Since 2008 THETA has been hosting  a lecture series THETA Rounds and inviting world experts to address various issues related to Health Technology Assesment field.
 

Topic: Prevention of cardiovascular disease – should we inform patients about reduced risk or increased longevity?
Lecturer: Ivar Kristiansen, PhD
Date:
Friday, Jan 31, 2014
Time:
1:00pm - 2:00pm
Venue:
Leslie Dan Pharmacy Bld, 144 College St., Rm 850

 


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.
 

Topic: The perilous promise of privacy: Health disclosures in a brave new world
Lecturer: Ester Moher, PhD
Date: Friday, Jan 17, 2014
Time: 1:00pm - 2:00pm
Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.

Topic: Mapping recent and current trends in pharmaceutical regulation: implications for innovation, safety and the cost-effective use of new medicines
Lecturer: Courtney Davis, PhD
Date: Friday, December 13, 2013
                               Time: 1:00pm - 2:00pm
                               Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.

Topic: From Papanicolaou to Papilloma: the corporatisation of cancer screening innovation
Lecturer: Stuart Hogarth, PhD
Date: Friday, Nov 29, 2013
Time: 1:00pm - 2:00pm
                              Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850


THETA Rounds
Topic: Adoption and cost effectiveness of breast cancer radiotherapy technologies: Quantitative and qualitative evaluation
Lecturer: Heather Taffet Gold, PhD
Date: Friday, Nov 8, 2013
Time: 1:00pm - 2:00pm
Venue: Leslie Dan Pharmacy Bld, 144 College St., Rm 850

Pressure Ulcer Multi‐disciplinary Teams via Telemedicine (PUMTT) KT Seminar

Pressure Ulcer Prevention in Long Term Care Facilities Knowledge Exchange & Results Dissemination,

THETA Collaborative is organizing a KT Seminar with intention to:

  • To share research results from the PUMTT study – a project developed by THETA with the support of Health Quality Ontario, Canadian Patient Safety Institute, Community Care Access Centres – with healthcare partners in Long Term Care facilities
  • To exchange ideas for a future research agenda and collaboration with the Long Term Care facilities

Time: Monday, October 7, 2013, 1- 4pm

Venue: Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto

Webinar: Available upon request, please email Joanna Bielecki for invitation, at: joanna.bielecki@theta.utoronto.ca


THETA Rounds

Since 2008 THETA has been hosting lecture series and inviting world experts to address various issues related to HTA. The sessions are held twice a month on Fridays 1:00pm - 2:00pm, at Leslie Dan Pharmacy Building, University of Toronto, 144 College Street, Room 850.
 
Sep 20, 2013:
An introduction to network meta-analysis (methods and applications) and why we should care about it.
Petros Pechlivanoglou, MSc, PhD, Research Associate at THETA

 

 

NEWS

THETA Collaborative presents at the upcoming Society for Medical Decision Making (SMDM) 2014 – 36th Annual North American Meeting. This year’s theme: Medical Decision Making Among Diverse Populations: Advancing Practice, Policy, and Science, October 18 - 22, 2014, Miami, FL.

SMDM 2014

Oral Presentation

Implementation Challenges of a Community-Based Pragmatic Randomized Controlled Trial in Wound Care. Josephine F Wong, MD, Valeria E. Rac, MD, PhD, Nicholas Mitsakakis, MSc, PhD, Eva Haratsidis, BSc, RN and Murray D. Krahn, MD, MSc. 

Poster Presentations

Cost-Effectiveness Analysis of Palliative Team Care for Patients Nearing End-Of-Life. Ba' Pham, MSc, PhD (c), Robert A. Fowler, MD, MSc, Peter Tanuseputro, MD, MHSc, Douglas Manuel, MD, MSc, Nancy Sikich, MSc, Shamara Baidoobonso, MSc, PhD, Petros Pechlivanoglou, PhD, Les Levin, MD, MSc and Murray D. Krahn, MD, MSc.

 Analysis of Healthcare Costs in Patients with Acute Whiplash-Associated Disorders Using Zero-Adjusted Gamma Models. Shahriar Shams, MA, Lusine Abrahamyan, MD, MPH, PhD, Gabrielle van der Velde, DC, PhD and Nicholas Mitsakakis, MSc, PhD. 

Cost-Effectiveness of Hepatitis B Virus Screening Before Adjuvant Chemotherapy in Patients with Early Stage Breast Cancer. William W. L. Wong, PhD, Lisa K. Hicks, MD, MSc, Hong Anh Tu, PhD, Murray D. Krahn, MD, MSc, Kathleen I. Pritchard, MD, MSc, Jordan J. Feld, MD, MPH and Kelvin Chan, MD, MSc.  

Cost-Effectiveness of Screening Hepatitis C in Canada. William W. L. Wong, PhD, Hong Anh Tu, PhD, Jordan J. Feld, MD, MPH, Tom Wong, MD, MPH and Murray D. Krahn, MD, MSc.  

Cost Effectiveness Analysis of Systematic Referral to Multidisciplinary Wound Care Teams in Ontario. Evidence from the Wound Interdisciplinary Teams (Wit) Trial. Mengzhu Jiang, MSc, Petros Pechlivanoglou, PhD, Josephine F Wong, MD, Nicholas Mitsakakis, MSc, PhD, Steven M. Carcone, MSc, Ba' Pham, MSc, PhD (c), Valeria E. Rac, MD, PhD and Murray D Krahn, MD, MSc.  

The Impact of Estimating Mortality Rates in Cost-Effectiveness Analysis: A Simulation StudyPetros Pechlivanoglou, PhD, Lusine Abrahamyan, MD, MPH, PhD, Ba' Pham, MSc, PhD (c), Mike Paulden, MA, MSc. and Murray D Krahn, MD, MSc.  

Wound Interdisciplinary Teams (Wit): A Community-Based Pragmatic Randomized Controlled Trial. Valeria E. Rac, MD PhD, Josephine Wong, MD, Nicholas Mitsakakis, MSc PhD, Petros Pechlivanoglou, PhD, Steven M. Carcone, MSc and Murray D. Krahn, MD, MSc.

Short Course

Complex Interventions for Comparative Effectiveness and Health Technology AssessmentValeria E. Rac, MD, PhD, Lusine Abrahamyan, MD, MPH,PhD and Murray D Krahn, MD, MSc.  

For more information about this conference, please check SMDM website.


The MaRS Excellence in Clinical Innovation and Technology Evaluation program (MaRS EXCITE), is now accepting applications! Apply by September 19, 2014.

MaRS EXCITE invites all medical device companies and innovators to apply to the program so that disruptive effective health technologies can get to market faster for improved health outcomes – in Ontario and globally.
EXCITE is a partnership between government, the healthcare system, academia, clinicians and industry, launched in late 2011.
At the end of the program, companies receive a high quality EXCITE core evidentiary bundle, they can use for both Health Canada licensing and an application to the Ontario Health Technology Advisory Committee (OHTAC) for recommendation to the Ontario Ministry of Health and Long Term Care and other reimbursement and purchasing reviewers.
Why apply?

  • EXCITE’s single, harmonized process mitigates risk and costs to investors and industry through pre market endorsements and increased efficiency
  • Gain earlier feedback on technology from regulators, payers, clinical experts and market experts to reduce delays and unnecessary development costs
  • Provides way to engage health system and negotiate conditions for adoption before launch
  • Multicentre studies involving markets of choice creates an efficient single platform to evaluate technologies across multiple jurisdictions in tandem with regulators and payers via EXCITE model

Current participants
11 technologies have been prioritized by the Ontario health system for the EXCITE program. For information on current participants: Medtronic of Canada, Apnea Dx, and Rna Diagnostics, click here.
How to apply
For more information on eligibility criteria and how to apply, visit the “How to Apply to EXCITE” section. Applications are due on September 19, 2014.
EXCITE Infosession
EXCITE will be holding an infosession with the opportunity for Q & A on August 21, 2014 from 2:00 p.m to 3:00 p.m at the MaRS Centre.
Sign up for the infosession today >>
For more information on EXCITE, please visit our website


THETA's study on  Mapping the Myelofibrosis Symptom Assessment Form (MFSAF) and Myeloproliferative Neoplasm Symptom Assessment From (MPN-SAF) to the EQ-5D is still enrolling participants.

The purpose of this study is to develop a statistical model to map scores on two myelofibrosis (MF)-specific descriptive quality of life instruments, the Myelofibrosis Symptom Assessment Form (MFSAF) and Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF), and the EQ-5D, a generic preference-based utility instrument. This will enable the estimation of utility values based on MFSAF and MPN-SAF data. We are looking for the optimal statistical model and algorithm to map the MFSAF and MPN-SAF to the EQ-5D.

The team conducting this study is still looking for eligible participants. Please contact Chang Ho Lee at changho.lee@mail.utoronto.ca or 647-982-7317, if you are or know a patient diagnosed with MF and you are interested in participating in the survey. For more information about this study please go to our Current Studies page.


Congratulations to Dr. Claire de Oliveira and Dr. Murray Krahn newest recipients of CIHR Partnerships for Health System Improvement Grant!

Canadian Institutes of Health Research recently awarded Claire de Oliveira, MA PhD and Murray Krahn, MD MSc the Partnerships for Health System Improvement Grant in 2013-2014 Competition. The proposed study "Using Administrative Health Care Data to Inform Cancer Care Policy in Canada" will measure costs of cancer care for patients diagnosed with prostate, breast, colorectal or lung cancer in British Columbia, Manitoba, Ontario, Québec and Nova Scotia a health system perspective, and to determine the factors that influence utilization and costs.

Principal Investigator(s): De Oliveira, Claire; Matheson, Garth R; Krahn, Murray D

Please check CIHR website for more details.


Dr. Murray Krahn received of 2014 Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment

Video of Dr Krahn introduction and his available here.


Dr. William Wong receives one-year operating grant from the Canadian Institutes of Health Research. Congratulations!!!

Dr. Wong, THETA's decision modeller, is a new recipient of a one-year CIHR operating grant – Hepatitis C Priority Announcement to conduct a pilot study. His grant titled “Cross sectional and longitudinal measures of quality of life and utility among patients with chronic hepatitis C virus infection”

Co-PI: Krahn M.. Co-Investigators: Bruneau J., Feld J., Feng Z.Z., Lee S.S., Mitsakakis, N. Myers, R.P., Pechlivanoglous, P., Powis, J., Rac, V.E

Please check CIHR website for more details.


Dr. Harindra Wijeysundera and Dr. William Wong's work described in the latest Elsevier press release.

On June 3, 2014 in  Philadelphia, PA, Elsevier published a news release commenting on the results of an article published in Canadian Journal of Cardiology by Dr. Harindra Wijeysundera and Dr. William Wong, et al.: "Impact of wait times on the effectiveness of transcatheter aortic-valve replacement (TAVR) in severe aortic valve disease: a discrete event simulation model".

A team of investigators from the University of Toronto including Dr. William Wong, and the Institute for Clinical Evaluative Sciences in Toronto used mathematical modelling to simulate the results from the PARTNER randomized trial with increasing TAVR wait times. “To our knowledge, our study is the first in the literature to evaluate the effect of delayed access to TAVR, and provides insight into the importance of wait time on outcomes,” says lead investigator Harindra C. Wijeysundera, MD, PhD, of the Schulich Heart Centre, University of Toronto.

Addtional Resources:

Full text of the Elsevier press release

“Impact of Wait Times on the Effectiveness of Transcatheter Aortic Valve Replacement in Severe Aortic Valve Disease: A Discrete Event Simulation Model,” by Harindra C. Wijeysundera, MD, PhD, William W.L. Wong, PhD, Maria C. Bennell, MSc, MPH, Stephen E. Fremes, MD, Sam Radhakrishnan, MD, Mark Peterson, MD, PhD, and Dennis T. Ko, MD, MSc, DOI: http://dx.doi.org/10.1016/j.cjca.2014.03.009.

Editorial: “Monitoring Wait Times for Transcatheter Aortic Valve Implantation: A Need for National Benchmarks,” by Sandra Lauck, RN, PhD, Dion Stub, MBBS, PhD, and John Webb, MD, DOI: http://dx.doi.org/10.1016/j.cjca.2014.05.006.

Science Newsline Medicine
Bio_Medicine


THETA receives the Health Technology Fund Program Award

Health Quality Ontario’s (HQO) recently announced the results of the 2014/2017 Health Technology Fund Program Request for Proposal Competition. After a rigorous, competitive process four successful candidates were selected, among them the Toronto Health Economics and Technology Assessment Collaborative (THETA).

The Health Technology Fund (HTF) Program promotes evidence-based analyses and supports the operation of Evidence-Based Program (EBP) Centers that focus on three areas: decision analyses/economic evaluations, evidence synthesis and field evaluations or usability studies.


Dr. Murray Krahn receives of 2014 Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment (HTA)

Sincere congratulations from the entire THETA team to our Program Director, Dr. Murray Krahn on receiving the prestigious Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment from CADTH and HTA community. Dr. Krahn received the award at 2014 CADTH Annual Meeting during an official Awards Luncheon ceremony.
Dr. Brian O’Rourke, President and CEO of CADTH stated “Dr. Murray Krahn has long been one of the brightest leaders in the field of HTA in Canada. This recognition is a testament to his exceptional contributions to the methodology of HTA, but also his dedication to nurturing and mentoring the next generation of scientists.”
The Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment recognizes and celebrates individuals whose outstanding achievements have significantly advanced the field of health technology assessment, evidence-based drug reviews, or optimal technology utilization in Canada. Please read the official announcement at CADTH website.

   


Dr. Petros Pechlivanoglou teaches at School of Pharmacy, Addis-Ababa University, Ethiopia

In 2008, the University of Toronto and the Addis-Ababa University in Ethiopia formed the Toronto Addis Ababa Academic Collaboration (TAAAC) with the aim of building and strengthening capacity and sustainability in medical specialities and other health and non-health professional programs in Addis Ababa.  Under the leadership of Dr. Heather Boon, the Leslie Dan Faculty of Pharmacy has partnered with the School of Pharmacy at Addis Ababa University to establish a PhD program in Social Pharmacy at AAU. As part of this collaboration, the Leslie Dan Faculty of Pharmacy has committed to provide faculty members to teach graduate courses in Addis.  Most recently, Dr. Petros Pechlivanoglou, one of THETA's health economists taught a  graduate course in Pharmacoeconomics at the School of Pharmacy of Addis Ababa University. The course gave Ethiopian graduate pharmacy students the opportunity to familiarize themselves with the principles of economic evaluation of pharmaceutical products, technologies and services, as well as to implement these principles in healthcare decision problems. The experience was mutually rewarding as it gave Petros a better understanding of the peculiarities associated with conducting economic evaluations in low-income countries as well as it exposed him to the friendly, generous, hospitable and historically rich Ethiopian culture.

In addition to providing this graduate course, THETA will be hosting, from April on, one of the PhD students from the school of Pharmacy of Addis Ababa University. Mr. Eskinder Eshetu Ali will be visiting the Leslie Dan Faculty of Pharmacy for the next three  months to analyze the effects and costs of building capacity in mental health through the TAAAC program.

School of Pharmacy at Addis Ababa University

 


THETA's Health Technology Assessment Institute 2014

THETA together with the Department of Community Health and Epidemiology at Dalhousie University in collaboration with the Institute of Health, Policy, Management and Evaluation, Leslie Dan Faculty of Pharmacy, and the CIHR-STIHR Health Care, Technology and Place Program will host the 2014 Health Technology Assessment Institute for Decision Makers.
The HTA Institute will bring together experts from a range of disciplines to provide attendees with pragmatic tools for HTA. This three-day intensive course will be useful to individuals who use HTA to make decisions relating to drugs, devices, and programs.

Date: July 14-16, 2014
Place: Dalhousie University
Registration date: April 15th.


THETA is happy to announce the launch of SIESTA!

SIESTA Home Sleep Study with ApneaDx™ for the Diagnosis and Management of Obstructive Sleep Apnea proposes to examine the validity, effectiveness, and cost-effectiveness of ApneaDx™, a new single-channel portable monitor designed to capture and analyze breath sounds to detect sleep apnea versus in-laboratory overnight sleep study with polysomnography – the gold standard for the diagnosis and management of obstructive sleep apnea.
SIESTA is both a multi-centre prospective validation study, as well as a pragmatic randomized single-blinded two armed non-inferiority trial. With a planned sample size of 330 participants, SIESTA will take approximately two years to complete. SIESTA is currently at the recruitment stage at the Kingston and Hamilton study sites. Dr. Mike Fitzpatrick is the lead Clinical Investigator at the Kingston Sleep Disorders Laboratory, with Nancy Farr as the onsite Study Coordinator. At the Hamilton Sleep Disorders Clinic, we have Dr. Ray Gottschalk as the Clinical Investigator and Jason Myers as the onsite Study Coordinator. REB submission is underway for our third site, Sleep & Apnea Assessment Unit in London Health Sciences Centre - Victoria Hospital with Dr. Charlie George.
ApneaDx™ is one of the first three companies selected by the MaRS Excellence in Clinical Innovation and Technology Evaluation (“EXCITE”) program.


Dr. Nicholas Mitsakakis organized a General Invited Session at the Annual Meeting of the Statistical Society of Canada (SSC).

This year University of Toronto is hosting the 2014 Annual Meeting of the Statistical Society of Canada (SSC) in May 25-28, 2014. THETA biostatistician Nicholas Mitsakakis, Assistant Professor, University of Toronto, and Eleanor Pullenayegum, Associate Professor, University of Toronto and  Scientist at the Hospital for Sick Children, organized a General Invited Session: Statistical Issues in Health Economics and Health Technology Assessment. The session will feature three prominent speakers:

Andy Willan, Professor, University of Toronto
Kristian Thorlund, Assistant Professor, McMaster University
Heejung Bang, Professor, University of California at Davis


THETA hosts HTA researchers from Norway

THETA has invited Professor Ivar Sønbø Kristiansen and his team to an all day workshop to explore common areas of research interest and avenues for future collaboration. Professor Kristiansen is a member of the Economic Evaluation of Health Technologies research group from the University of Oslo. Associate Professor Torbjørn Wisløff, also a member of University of Oslo research team, works for the Norwegian Knowledge Centre for the Health Services (NOKC). The meeting will take place at THETA offices on January 30th, 2014. Meeting Agenda.


Congratulations to Dr. Beate Sander...

Dr. Sander, THETA's investigator, is a new receipient of the three-year CIHR operating grant. Her grant titled “Estimating longitudinal healthcare costs for infectious diseases using administrative data” amounts to $474,627.
Co-PI: Jeff Kwong. Co-Investigators: Peter Austin, Natasha Crowcroft, Nick Daneman, Jordan Feld, Allison McGeer, Natasha Nanwa.


Dr. Pechlivanoglou's systematic review gets press exposure.

On September 6, 2013 Reuters Health (NEW YORK) released a news story commenting on the results of a published systematic review by Dr. Petros Pechlivanoglou: "Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review". After Dr. Pechlivanoglou email discussion with Reuters Health the story appeared in the NewsDaily - a service of the science news site ScienceDaily one of the Internet’s most popular science news web sites, and P4 Healthcare -  the online health care community that connects physicians, patients, pharmaceutical companies, and payers, with the leading specialty therapeutic practices.


THETA Staff present at this year's SMDM 2013 - 35th Annual Meeting of the Society for Medical Decision Making.

The theme: Bench, Bedside and Beyond: Medical Decision Making and Public Policy, October 19 - 23, 2013, Baltimore, MD

The Hepatitis C Drug Pipeline: Collaboration Between Academic and Hta Agency Partners to Develop an Early Economic Model. William W. L. Wong, Hong Anh Tu, Wendong Chen, Jordan J. Feld, Kristen Chelak,  Karen M. Lee, and Murray D. Krahn, The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Impact of Increasing Wait Times on the Effectiveness of Transcatheter Aortic-Valve Replacement (Tavr) in High-Risk and Inoperable Patients with Severe Aortic Disease: a Discrete Event Simulation Model. Harindra C. Wijeysundera, William W. L. Wong, Maria C. Bennell, Stephen E. Fremes, Sam Radhakrishnan,  Mark Peterson,  and Dennis T. Ko The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Using Projections of Life Expectancy in Economic Decision Making P.Pechlivanoglou, M. Paulden, W.Wong, S. Bermingham , B. Pham, The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Using Value of Information Methods When the Disease is Rare and the Treatment is Expensive – The Example of Hemophilia A. Lusine Abrahamyan, Andrew R. Willan, Joseph Beyene, Marjorie Mclimont, Victor Blanchette,  Brian M. Feldman for the Canadian Hemophilia Primary Prophylaxis (CHPS) Study Group. The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Poster Presentation.

Characteristics of Multi-disciplinary Heart Failure Clinics that Predict 1-year Cumulative Health Care Costs: A Population-based Study. Harindra C. Wijeysundera, Peter C. Austin, Xuesong Wang, Maria C. Bennell, Lusine Abrahamyan, Dennis T. Ko, Jack V. Tu, Murray Krahn. The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MD, U.S.A, Oral Presentation.

Cost-Effectiveness of Education and Activation, and a Rehabilitation Program, Compared to the Legislated Standard of Care for Acute Whiplash Injury in Ontario. Gabrielle van der Velde, DC, PhD1, Lusine Abrahamyan1, Pierre Coté2, Eleanor Boyle3, Heather Shearer, DC, FCCS(C), MSc2, Maja Stupar2, Craig Jacobs, DC, MSc, FCCS(C)2, Jeffrey Hoch4, Patrick Loisel5, Petros Pechlivanoglou, PhD1, David Cassidy3, and Andrew R. Willan, PhD7, The 35th Annual Meeting of the Society for Medical Decision Making, Baltimore, MA, U.S.A, Poster Presentation. (1)Toronto Health Economics & Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, (2)UOIT-CMCC Centre for the Study of Disability Prevention and Rehabilitation, Toronto, ON, Canada, (3)University of Southern Denmark, Odense, Denmark, (4)Cancer Care Ontario, Toronto, ON, Canada, (5)University of Toronto, Toronto, ON, Canada, (6)SickKids Research Institute, Toronto, ON, Canada


 Personalized Medicine: Genomic Test for Breast Cancer Recurrence Found to be Cost Effective.

THETA press release - TORONTO, July 15,2013

The 6th Annual THETA Symposium and THETA KT Day

Both events gathered rave reviews from attendees. Many aspects were praised: select speakers, interesting topics, and choice of venue. Please check some presentations  posted under Publications and Knowledge Translation tab on THETA "Knowledge Translation to Policy" Day and Symposium page.


Dr. Murray Krahn delivered a winning “big idea for HTA” speech at the 2013 CADTH Symposium closing plenary.

Dr. Murray Krahn idea is early health technology assessment - bringing together scientists, payers, and innovators and using well-developed HTA methods to shorten timelines around the evaluation of new technologies.

The winning idea will be presented by Dr. Krahn at the next 2014 Symposium in a workshop format.

Please see Dr. Krahn’s speech at the closing plenary below.


THETA's Health Technology Assessment Institute 2013

The 2013 Health Technology Assessment Institute for Decision Makers will be held on JUNE 26-28, 2013. Please save the date.Registration is now open!


The 6th Annual THETA Symposium!

When: Thursday, May 30th, 2013

Where: Casa Loma, Toronto

This year’s theme will be “End-of-Life Care”, lead by Dr. Robert Fowler, Senior Scientist at Sunnybrook Research Institute. Please see the attached agenda for this meenting.

THETA KT Day

When: Wednesday, May 29th, 2013

Where: Casa Loma, Toronto

THETA would like to invite you to our fourth annual "Knowledge Translation to Policy" Day.

This year’s topic will focus on early health technology assessment (i.e. “Early HTA”). This new HTA research model is emerging, in which scientists, payers, and innovators work together early in the technology development process. This ensures that the clinical evidence will meet the needs of payers (e.g. Ministries of Health) and regulators (e.g. Health Canada) when it is brought to market, and is consonant with the needs of users.

We think it will be an interesting and interactive day, and look forward to seeing you there. Please see the attached agenda.


Dr. Krahn and other Department of Pharmacy researchers' excellence in education, research and program development linked to 11th best in the world ranking and top-ranking in Canada for the Department.

 

Read the full article: "Message from the Dean" in Pharmacy Alumni magazine here.

 

 

 


SAVE THE DATE: THETA's Health Technology Assessment Institute 2013

The 2013 Health Technology Assessment Institute for Decision Makers will be held on JUNE 26-28, 2013. Please save the date. Registration will open on March 15th.


THETA hosts international PRECIS Meeting - PRagmatic Explanatory Continuum Indicator Summaries - Pragmatic trial design tool

When: Monday, 11th March 2013, 9:30-4:30 p.m.

Where: Leslie Dan Pharmacy Building, University of Toronto

Host: Toronto Health Economics and Technology Assessment Collaborative (THETA). Please see the Agenda and a list of participants here.


PLEASE SAVE THE DATE - for the 6th Annual THETA Symposium!

When: Thursday, May 30th, 2013

Where: Casa Loma, Toronto

This year’s theme will be “End-of-Life Care”, lead by Dr. Robert Fowler, Senior Scientist at Sunnybrook Research Institute. Please see the attached flyer here – a detailed programme will be circulated in early spring.


Centre for the Evaluation of Technological Innovation gets funded through CFI New Initiatives Fund grant

Dr. Murray Krahn, the F. Norman Hughes Chair in Pharmacoeconomics at the Leslie Dan Faculty of Pharmacy, and Director of the Toronto Health Economics and Technology Assessment Collaborative (THETA), is the recent recipient of a five-year Canada Foundation for Innovation (CFI) New Initiatives Fund.

 

 

 


PLEASE SAVE THE DATE - THETA KT Day

What: The THETA Collaborative 4th Annual "Knowledge Translation to Policy" Day

When: Wednesday, May 29th, 2013

Where: Casa Loma, Toronto

THETA Collaborative is the Toronto Health Economics and Technology Assessment Collaborative. We are funded by the Ontario Ministry of Health and Long-Term Care to do policy relevant research, and support the work of Health Quality Ontario and the Ontario Health Technology Advisory Committee.

This year’s topic will focus on early health technology assessment (i.e. “Early HTA”). This new HTA research model is emerging, in which scientists, payers, and innovators work together early in the technology development process. This ensures that the clinical evidence will meet the needs of payers (e.g. Ministries of Health) and regulators (e.g. Health Canada) when it is brought to market, and is consonant with the needs of users.

As always, it will be an exciting day, and THETA really hopes to see you there. Please see the attached flyer here – a provisional agenda will follow shortly.


Ba' Pham presents his newest paper at the Canadian Association of Wound Care (CAWC) Conference in London, Ontario.

Presentation Topic: Great Canadian Bandaging Trial – Cost-effectiveness Analysis and Quality-of-life Results

Presenters: Ba’ Pham Conference, venue, location & time: CAWC Conference, London Convention Centre, London, Ontario.

Related articles:


Please check THETA News Archive for older items

Back to Top

 

Introduction of the recipient of Dr. Jill M. Sanders Award of Excellence in HTA - Dr Murray Krahn

 

Dr Murray Krahn acceptance speech

  • OUR PARTNERS
  • Health Quality Ontario
  • Cancer Care Ontario
  • Leslie Dan Faculty of Pharmacy at the University of Toronto
  • Toronto General Hospital
Description

Loading  Loading...

Tip